Bill number does not exist. Enter a vaild keyword.

Committee Testimony and Witness Signup

SB1019 - Health Benefit Plans - Prescription Drugs - Rebates and Calculation of Cost Sharing Requirements

Finance 3/13/2024 1:00:00 PM
As of: 10/9/2024 3:54:08 AM
Name Organization Position Testimony Committee
Senator Washington, A., Senator Washington, A. FAV In Person - Oral Testimony
FIN
Wood, Shannon National Multiple Sclerosis Society FAV NMSS Shannon Wood SB 1019 Testimony Favorable.pdf FIN
Robinson, Kimberly The Cigna Group UNF In Person - Oral Testimony
FIN
Fesche, Camille RWL UNF In Person - Oral Testimony
FIN
Johansen, Michael RWL UNF In Person - Oral Testimony
FIN
Celentano, Matthew Funk & Bolton, P.A. UNF In Person - Oral Testimony
FIN
Shaul, Stephen FAV In Person - Oral Testimony
MD Senate Finance Committee - SB1019.pdf
FIN
Vetter, Drew FAV SB1019_FAV_MTC_Health Benefit Plans - Prescription FIN
Kauffman, Danna FAV SB1019_FAV_MedChi_Health Benefit Plans - Prescript FIN
Schulz, Kelly Maryland Tech Council FAV In Person - Oral Testimony
FIN
Jones, Sarah Eosinophilic & Rare Disease Cooperative FAV Virtual - Oral Testimony
FIN
Wood, Sarah Diabetes Patient Advocacy Coalition FAV In Person - Oral Testimony
FIN
VALANOS, ELENI FAV ATAP Support Letter - MD SB 1019 03.13.24.pdf FIN
Lake, Keith AHIP - Washington, DC UNF In Person - Oral Testimony
AHIP Comments_MD SB 1019 POS rebates_3.12.24.pdf
FIN
Callahan, Erin Diabetes Patient FAV Virtual - Oral Testimony
FIN
Bajaj, Joshan Diabetes Patient Advocate FAV Virtual - Oral Testimony
FIN
Sachs, Claire TPAC Consulting and The Patient Advocate's Chronicle FAV In Person - Oral Testimony
MD SB1019 Written Testimony.pdf
FIN
Washington, Alonzo FAV Testimony in Favor of SB-1019, Maryland Share the FIN
Testimony, All N/A Merged Testimony as of 3-12-2024 at 956 PM FIN
Click to return on the top page